Two studies examined the CD4/CD8 ratio in the entire tumor area: one study found a better survival in patients with high CD4/CD8 ratio [59], but the other study found a worse survival correlated with high CD4/CD8 ratio instead [55]. The gene discussed is CD8A; the disease is neoplasm.